Paradigm Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-130
| Closed | -$32.4K | – | 410 |
|
|
2020
Q3 | $32.4K | Hold |
130
| – | – | 0.01% | 374 |
|
|
2020
Q2 | $45.2K | Buy |
+130
| New | +$45.2K | 0.01% | 373 |
|
|
2018
Q4 | – | Sell |
-40
| Closed | -$36.6K | – | 418 |
|
|
2018
Q3 | $36.6K | Buy |
40
+10
| +33% | +$9.14K | 0.01% | 387 |
|
|
2018
Q2 | $22K | Hold |
30
| – | – | 0.01% | 394 |
|
|
2018
Q1 | $47.8K | Hold |
30
| – | – | 0.01% | 354 |
|
|
2017
Q4 | $26.9K | Sell |
30
-187
| -86% | -$168K | 0.01% | 383 |
|
|
2017
Q3 | $78K | Hold |
217
| – | – | 0.02% | 342 |
|
|
2017
Q2 | $63.5K | Buy |
217
+10
| +5% | +$2.93K | 0.01% | 487 |
|
|
2017
Q1 | $72.8K | Buy |
+207
| New | +$72.8K | 0.01% | 557 |
|
|
2016
Q3 | – | Sell |
-467
| Closed | -$99.6K | – | 738 |
|
|
2016
Q2 | $99.6K | Sell |
467
-680
| -59% | -$145K | 0.02% | 451 |
|
|
2016
Q1 | $237K | Hold |
1,147
| – | – | 0.04% | 294 |
|
|
2015
Q4 | $290K | Buy |
+1,147
| New | +$290K | 0.05% | 326 |
|